STOCK TITAN

[Form 4] NEOGEN CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Neogen Corporation (NEOG) reported an insider transaction by a director. On 10/24/2025, the director acquired 19,386 shares of common stock at a $6.19 price and now holds 19,386 shares directly.

The filing also reports a grant of 49,929 stock options with a $6.19 exercise price, expiring on 10/24/2035. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.

Neogen Corporation (NEOG) ha riportato una transazione interna da parte di un direttore. Il 24/10/2025, il direttore ha acquisito 19.386 azioni ordinarie al prezzo di $6,19 e ora possiede 19.386 azioni direttamente.

La segnalazione riporta anche una concessione di 49.929 opzioni su azioni con un prezzo di esercizio di $6,19, scadono il 24/10/2035. Le opzioni e le RSU vestono in rate annuali uguali in ciascuna delle prime tre date di anniversario delle concessioni.

Neogen Corporation (NEOG) informó una transacción interna por parte de un director. El 24/10/2025, el director adquirió 19.386 acciones comunes a un precio de $6.19 y ahora posee 19.386 acciones directamente.

El expediente también informa una concesión de 49.929 opciones sobre acciones con un precio de ejercicio de $6.19, que expiran el 24/10/2035. Las opciones y las RSU vencen en cuotas iguales anuales en cada una de las primeras tres fechas de aniversario de las concesiones.

Neogen Corporation (NEOG) 이사가 내부 거래를 보고했습니다. 2025년 10월 24일, 이사는 공통 주식 19,386주$6.19에 취득했고 현재 직접 19,386주를 보유합니다.

신고서는 또한 49,929주 옵션이 부여되었고 행사 가격은 $6.19이며 만료일은 2035년 10월 24일입니다. 옵션과 RSU는 부여일의 이후 첫 세 해의 각 기념일에 동일한 연간 분할로 vest됩니다.

Neogen Corporation (NEOG) a fait état d'une transaction d'initié par un administrateur. Le 24/10/2025, l'administrateur a acquis 19 386 actions ordinaires au prix de $6,19 et détient désormais directement 19 386 actions.

Le document indique également une attribution de 49 929 options d'achat avec un prix d'exercice de $6,19, arrivant à expiration le 24/10/2035. Les options et les RSU se vestent par des versements annuels égaux sur chacune des trois premières dates d'anniversaire des attributions.

Neogen Corporation (NEOG) meldete eine Insider-Transaktion durch einen Direktor. Am 24.10.2025 erwarb der Direktor 19.386 Stammaktien zu einem Preis von $6,19 und hält nun direkt 19.386 Aktien.

Die Einreichung berichtet außerdem über die Zuteilung von 49.929 Aktienoptionen mit einem Ausübungspreis von $6,19, fällig am 24.10.2035. Die Optionen und RSUs vesten in gleichen jährlichen Raten an jedem der ersten drei Jahrestage der Gewährung.

شركة Neogen Corporation (NEOG) أبلغت عن صفقة داخلية من قبل مدير. في 24/10/2025، اشترى المدير 19,386 سهماً عادياً بسعر $6.19 وهو يمتلك الآن 19,386 سهماً بشكل مباشر.

كما تشير الإفادة إلى منحة من 49,929 خياراً للأسهم مع سعر تنفيذ قدره $6.19، منتهية صلاحيتها في 24/10/2035. وتستحق الخيارات وRSUs بالتدريج وفق دفعات سنوية متساوية على أول ثلاث تواريخ ذكرى للمنح.

Positive
  • None.
Negative
  • None.

Neogen Corporation (NEOG) ha riportato una transazione interna da parte di un direttore. Il 24/10/2025, il direttore ha acquisito 19.386 azioni ordinarie al prezzo di $6,19 e ora possiede 19.386 azioni direttamente.

La segnalazione riporta anche una concessione di 49.929 opzioni su azioni con un prezzo di esercizio di $6,19, scadono il 24/10/2035. Le opzioni e le RSU vestono in rate annuali uguali in ciascuna delle prime tre date di anniversario delle concessioni.

Neogen Corporation (NEOG) informó una transacción interna por parte de un director. El 24/10/2025, el director adquirió 19.386 acciones comunes a un precio de $6.19 y ahora posee 19.386 acciones directamente.

El expediente también informa una concesión de 49.929 opciones sobre acciones con un precio de ejercicio de $6.19, que expiran el 24/10/2035. Las opciones y las RSU vencen en cuotas iguales anuales en cada una de las primeras tres fechas de aniversario de las concesiones.

Neogen Corporation (NEOG) 이사가 내부 거래를 보고했습니다. 2025년 10월 24일, 이사는 공통 주식 19,386주$6.19에 취득했고 현재 직접 19,386주를 보유합니다.

신고서는 또한 49,929주 옵션이 부여되었고 행사 가격은 $6.19이며 만료일은 2035년 10월 24일입니다. 옵션과 RSU는 부여일의 이후 첫 세 해의 각 기념일에 동일한 연간 분할로 vest됩니다.

Neogen Corporation (NEOG) a fait état d'une transaction d'initié par un administrateur. Le 24/10/2025, l'administrateur a acquis 19 386 actions ordinaires au prix de $6,19 et détient désormais directement 19 386 actions.

Le document indique également une attribution de 49 929 options d'achat avec un prix d'exercice de $6,19, arrivant à expiration le 24/10/2035. Les options et les RSU se vestent par des versements annuels égaux sur chacune des trois premières dates d'anniversaire des attributions.

Neogen Corporation (NEOG) meldete eine Insider-Transaktion durch einen Direktor. Am 24.10.2025 erwarb der Direktor 19.386 Stammaktien zu einem Preis von $6,19 und hält nun direkt 19.386 Aktien.

Die Einreichung berichtet außerdem über die Zuteilung von 49.929 Aktienoptionen mit einem Ausübungspreis von $6,19, fällig am 24.10.2035. Die Optionen und RSUs vesten in gleichen jährlichen Raten an jedem der ersten drei Jahrestage der Gewährung.

شركة Neogen Corporation (NEOG) أبلغت عن صفقة داخلية من قبل مدير. في 24/10/2025، اشترى المدير 19,386 سهماً عادياً بسعر $6.19 وهو يمتلك الآن 19,386 سهماً بشكل مباشر.

كما تشير الإفادة إلى منحة من 49,929 خياراً للأسهم مع سعر تنفيذ قدره $6.19، منتهية صلاحيتها في 24/10/2035. وتستحق الخيارات وRSUs بالتدريج وفق دفعات سنوية متساوية على أول ثلاث تواريخ ذكرى للمنح.

Neogen Corporation (NEOG) 报告了一笔由董事进行的内部交易。2025年10月24日,该董事以每股 $6.19 的价格购买了 19,386股普通股,现在直接持有 19,386 股。

申报还显示授予了 49,929 份股票期权,行使价为 $6.19,到期日为 2035-10-24。这些期权和 RSU 将在授予后的前3个周年日期以等额的年度分期 vest。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pelossof Avi

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/24/2025 A 19,386(1) A $6.19 19,386 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock (Right to Buy) $6.19 10/24/2025 A 49,929 (1) 10/24/2035 Common Stock 49,929 $0 49,929 D
Explanation of Responses:
1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
Christopher Sefcheck (Attorney in Fact) 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did NEOG report on this Form 4?

A director acquired 19,386 common shares and received 49,929 stock options on 10/24/2025.

What is the exercise price and expiration for the NEOG options?

The options have a $6.19 exercise price and expire on 10/24/2035.

How do the NEOG awards vest?

Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.

What is the insider’s relationship to NEOG?

The reporting person is a Director of Neogen Corporation.

How many NEOG shares are held after the transaction?

Following the transaction, the insider holds 19,386 shares directly and 49,929 options.

Was this filed by one reporting person?

Yes. The form indicates it was filed by one reporting person.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.34B
214.92M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING